Quantcast
Last updated on April 23, 2014 at 1:22 EDT

LightBridge Healthcare Research, Inc., The Alzheimer’s Caregiver, Adds New Board Member

July 30, 2012

Gustavo C. Román M.D., Professor of Neurology, Weill Cornell Medical College and Director of The Nantz National Alzheimer Center a scholarly partnership between The Methodist Hospital Research Institute, Weill Cornell Medical College, and the Weill Cornell Graduate School of Medical Sciences of Cornell University., to join board of LightBridge Healthcare Research, Inc.

San Antonio, Texas (PRWEB) July 30, 2012

The Alzheimer´s Caregiver today announced that Gustavo C. Román M.D., Professor of Neurology, Weill Cornell Medical College and Director of The Nantz National Alzheimer Center, Methodist Research Institute was appointed to the company´s board of directors.

“Dr. Roman is vastly experienced in various aspects of neurology including neuroepidemiology, cognitive neurology, vascular dementia and Alzheimer. Dr. Román has published extensively; and has more than 200 peer reviewed published articles, mainly in the field of dementia. He served as Editor-in-Chief of the journal Neuroepidemiology and is a member of the editorial board of the Journal of the Neurological Sciences, said Tom Elin, chairman of LightBridge Healthcare Research.

Dr. Roman currently serves as Director of The Nantz National Alzheimer Center a scholarly partnership between The Methodist Hospital Research Institute, Weill Cornell Medical College, and the Weill Cornell Graduate School of Medical Sciences of Cornell University.

Dr. Román will consult LightBridge on the overall medical and neurological content of its caregiver guide The Alzheimer´s Caregiver. This content will include among others Sleep Behavior Disorders, Assistance with Daily Living (ADL´s) such as Bathing, Showering and Dressing. Dr. Román will also review the guide for medical accuracy and applicability to dementia. The Alzheimer´s Caregiver is in both English and Spanish, as a native Spanish-speaker, Dr. Román will review the translations for accuracy, cultural relevance, and sensitivity.

Dr. Román served as an advisor to the US Food and Drug Administration and was Chief of the Neuroepidemiology Branch at the National Institutes of Health (NIH) where he helped develop cooperative international research programs. During his tenure at the NIH, Dr. Román was instrumental in organizing the international workshop that defined the criteria for vascular dementia for research studies.

The Alzheimer´s Caregiver is worldwide serving the 35.1 million persons with Alzheimer´s and their over 71 million caregiver´s. So we feel fortunate to have Dr. Roman on our board in light of the fact that Dr. Roman was elected to the board of directors of The World Federation of Neurology (WFN). Dr. Román is fluent in English, French and Spanish and has a large international patient population.

To be nominated as a trustee, candidates must have a national and international reputation in neurology and demonstrate a substantial commitment to the growth and development of the WFN. For more than 10 years, Dr. Roman has served as associate editor of the organization’s Journal of the Neurological Science, chaired its research group on neuroepidemiology, and worked on a number of its research groups and committees. The World Federation of Neurology is the international body representing the specialty of neurology in more than 100 countries and regions of the globe, with 108 member societies. Its purpose is to improve human health worldwide by promoting prevention and care of persons with disorders of the nervous system.

About The Alzheimer’s Caregiver:

The Alzheimer´s Caregiver provide the Alzheimer´s Caregivers worldwide with a comprehensive understanding of Alzheimer´s disease and care strategies based on research and real caregiver´s experience. It is funded through numerous competitive grants from the National Institute of Health in Washington DC.

For the original version on PRWeb visit: http://www.prweb.com/releases/prwebthealzheimerscaegiver/gustavoromanmd/prweb9741238.htm


Source: prweb